Mincoo's PDRN: Premium Nucleic‑Acid Regenerative Biomaterial
Powered by core PDRN manufacturing technology, Mincoo builds an integrated platform covering raw materials, finished products and customised solutions, delivering high‑performance biomaterials for global medical aesthetics, skincare and medical‑grade applications. We strive to be China's frontrunner in innovative PDRN technology development.
Proprietary separation and extraction technology delivers purity above 95%. It retains full biological activity while lowering safety risks brought by impurities.
Raw materials are traceable and sustainably harvested from certified FAO 61 fishing zones. The material features low allergenicity and low immunogenicity for reliable biocompatibility.
Average molecular weight spans 100‑3500 kDa. Custom adjustment is available to match diverse product positioning and formulation demands.
It adapts to multiple dosage forms, including liquid, lyophilized powder, and gel, suitable for cosmetic‑grade as well as medical‑grade formula development.
A full portfolio of biosafety and efficacy evaluation documents is ready to facilitate customers’ product registration and market filing procedures.
Manufacturing follows GMP standards. Critical quality indicators remain controllable across the whole production cycle for consistent batch‑to‑batch performance.
Mincoo PDRN brings stable, safe and customisable nucleic‑acid raw material options to global partners, supporting skin repair, regeneration and anti‑aging product innovation.
